Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
2(40%)
Results Posted
100%(3 trials)

Phase Distribution

Ph not_applicable
4
80%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Completed(3)

Detailed Status

Completed3
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
5
Active
2
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

completed360%
recruiting240%

Recent Activity

2 active trials
Showing 5 of 5
recruitingnot_applicable

The PEERLESS II Study

NCT06055920
recruitingnot_applicable

The PERSEVERE Study

NCT06588634
completednot_applicable

The PEERLESS Study

NCT05111613
completed

FlowTriever All-Comer Registry for Patient Safety and Hemodynamics

NCT03761173
completednot_applicable

FlowTriever Pulmonary Embolectomy Clinical Study

NCT02692586

Clinical Trials (5)

Showing 5 of 5 trials
NCT06055920Not Applicable

The PEERLESS II Study

Recruiting
NCT06588634Not Applicable

The PERSEVERE Study

Recruiting
NCT05111613Not Applicable

The PEERLESS Study

Completed
NCT03761173

FlowTriever All-Comer Registry for Patient Safety and Hemodynamics

Completed
NCT02692586Not Applicable

FlowTriever Pulmonary Embolectomy Clinical Study

Completed

All 5 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
5